• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

B7-H3 抑制 Vγ9Vδ2 T 细胞针对结肠癌细胞的 IFN-γ 依赖性细胞毒性。

B7-H3 inhibits the IFN-γ-dependent cytotoxicity of Vγ9Vδ2 T cells against colon cancer cells.

机构信息

Department of Gastroenterology, The First Affiliated Hospital of Soochow University, Suzhou, China.

Jiangsu Institute of Clinical Immunology, the First Affiliated Hospital of Soochow University, Suzhou, China.

出版信息

Oncoimmunology. 2020 Apr 14;9(1):1748991. doi: 10.1080/2162402X.2020.1748991. eCollection 2020.

DOI:10.1080/2162402X.2020.1748991
PMID:32363121
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7185217/
Abstract

The immunoregulatory protein B7-H3, a member of the B7 family, has been confirmed to be highly expressed in colon cancer. However, the exact influence of B7-H3 on the features and antitumor ability of γδT cells in colon cancer remains unknown. In the present study, we investigated that the proportions of B7-H3 γδT cells were distinctly increased in the peripheral blood and tumor tissues of colon cancer patients. B7-H3 blockade or knockdown promoted proliferation, inhibited cell apoptosis and induced the expression of activation markers (CD25 and CD69) on Vδ2 T cells. In contrast, treatment with the B7-H3 agonist 4H7 had the opposite effect. Furthermore, B7-H3 suppressed IFN-γ expression by inhibiting T-bet in Vδ2 T cells. Moreover, B7-H3 mediated the inhibition of Vδ2 T cell cytotoxicity via the downregulation of IFN-γ and perforin/granzyme B expression. More importantly, blocking the B7-H3 function significantly enhanced the cytotoxicity of Vδ2 T cells against colon cancer cells in vivo. Therefore, the inhibition or blockade of B7-H3 is a potential immunotherapeutic approach for colon cancer.

摘要

免疫调节蛋白 B7-H3 是 B7 家族的成员之一,已被证实在结肠癌中高度表达。然而,B7-H3 对结肠癌中 γδT 细胞的特征和抗肿瘤能力的确切影响尚不清楚。在本研究中,我们发现结肠癌患者的外周血和肿瘤组织中 B7-H3 γδT 细胞的比例明显增加。B7-H3 阻断或敲低促进了 Vδ2 T 细胞的增殖,抑制了细胞凋亡,并诱导了活化标志物(CD25 和 CD69)的表达。相比之下,B7-H3 激动剂 4H7 则产生相反的效果。此外,B7-H3 通过抑制 Vδ2 T 细胞中的 T-bet 来抑制 IFN-γ 的表达。此外,B7-H3 通过下调 IFN-γ 和穿孔素/颗粒酶 B 的表达来介导 Vδ2 T 细胞细胞毒性的抑制。更重要的是,阻断 B7-H3 的功能显著增强了 Vδ2 T 细胞对体内结肠癌细胞的细胞毒性。因此,抑制或阻断 B7-H3 是治疗结肠癌的一种潜在免疫治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5d9/7185217/7a6abd406b8b/koni-09-01-1748991-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5d9/7185217/47dff654a3d0/koni-09-01-1748991-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5d9/7185217/87d4605271c9/koni-09-01-1748991-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5d9/7185217/9738cb7f103c/koni-09-01-1748991-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5d9/7185217/631d06935027/koni-09-01-1748991-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5d9/7185217/9aa76c18d2e4/koni-09-01-1748991-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5d9/7185217/414c711000ac/koni-09-01-1748991-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5d9/7185217/5a3d2b0bdfdf/koni-09-01-1748991-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5d9/7185217/7a6abd406b8b/koni-09-01-1748991-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5d9/7185217/47dff654a3d0/koni-09-01-1748991-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5d9/7185217/87d4605271c9/koni-09-01-1748991-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5d9/7185217/9738cb7f103c/koni-09-01-1748991-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5d9/7185217/631d06935027/koni-09-01-1748991-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5d9/7185217/9aa76c18d2e4/koni-09-01-1748991-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5d9/7185217/414c711000ac/koni-09-01-1748991-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5d9/7185217/5a3d2b0bdfdf/koni-09-01-1748991-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5d9/7185217/7a6abd406b8b/koni-09-01-1748991-g008.jpg

相似文献

1
B7-H3 inhibits the IFN-γ-dependent cytotoxicity of Vγ9Vδ2 T cells against colon cancer cells.B7-H3 抑制 Vγ9Vδ2 T 细胞针对结肠癌细胞的 IFN-γ 依赖性细胞毒性。
Oncoimmunology. 2020 Apr 14;9(1):1748991. doi: 10.1080/2162402X.2020.1748991. eCollection 2020.
2
B7-H3 confers resistance to Vγ9Vδ2 T cell-mediated cytotoxicity in human colon cancer cells via the STAT3/ULBP2 axis.B7-H3 通过 STAT3/ULBP2 轴赋予人结肠癌细胞对 Vγ9Vδ2 T 细胞介导的细胞毒性的抗性。
Cancer Immunol Immunother. 2021 May;70(5):1213-1226. doi: 10.1007/s00262-020-02771-w. Epub 2020 Oct 29.
3
Tim-3 suppresses the killing effect of Vγ9Vδ2 T cells on colon cancer cells by reducing perforin and granzyme B expression.Tim-3 通过降低穿孔素和颗粒酶 B 的表达来抑制 Vγ9Vδ2 T 细胞对结肠癌细胞的杀伤作用。
Exp Cell Res. 2020 Jan 1;386(1):111719. doi: 10.1016/j.yexcr.2019.111719. Epub 2019 Nov 11.
4
B7-H3: a costimulatory molecule for T cell activation and IFN-gamma production.B7-H3:一种用于T细胞活化和干扰素-γ产生的共刺激分子。
Nat Immunol. 2001 Mar;2(3):269-74. doi: 10.1038/85339.
5
Hypoxia regulates the differentiation and anti-tumor effector functions of γδT cells in oral cancer.低氧调节口腔癌中 γδT 细胞的分化和抗肿瘤效应功能。
Clin Exp Immunol. 2020 Jul;201(1):40-57. doi: 10.1111/cei.13436. Epub 2020 May 18.
6
B7-H3 on breast cancer cell MCF7 inhibits IFN-γ release from tumour-infiltrating T cells.乳腺癌细胞MCF7上的B7-H3抑制肿瘤浸润T细胞释放IFN-γ。
Pathol Res Pract. 2021 Aug;224:153461. doi: 10.1016/j.prp.2021.153461. Epub 2021 May 5.
7
HDAC is indispensable for IFN-γ-induced B7-H1 expression in gastric cancer.组蛋白去乙酰化酶对于 IFN-γ 诱导胃癌中 B7-H1 的表达是不可或缺的。
Clin Epigenetics. 2018 Dec 11;10(1):153. doi: 10.1186/s13148-018-0589-6.
8
Blocking PD-1/PD-L1 by an ADCC enhanced anti-B7-H3/PD-1 fusion protein engages immune activation and cytotoxicity.阻断 PD-1/PD-L1 可通过 ADCC 增强的抗 B7-H3/PD-1 融合蛋白来激发免疫激活和细胞毒性。
Int Immunopharmacol. 2020 Jul;84:106584. doi: 10.1016/j.intimp.2020.106584. Epub 2020 May 15.
9
B7-H1 and B7-H3 are independent predictors of poor prognosis in patients with non-small cell lung cancer.B7-H1和B7-H3是非小细胞肺癌患者预后不良的独立预测指标。
Oncotarget. 2015 Feb 20;6(5):3452-61. doi: 10.18632/oncotarget.3097.
10
T cell cytotoxicity toward hematologic malignancy via B7-H3 targeting.通过靶向 B7-H3 实现 T 细胞对血液恶性肿瘤的细胞毒性作用。
Invest New Drugs. 2020 Jun;38(3):722-732. doi: 10.1007/s10637-019-00819-y. Epub 2019 Jul 3.

引用本文的文献

1
B7-H3 in Cancer Immunotherapy-Prospects and Challenges: A Review of the Literature.癌症免疫治疗中的B7-H3:前景与挑战——文献综述
Cells. 2025 Aug 6;14(15):1209. doi: 10.3390/cells14151209.
2
From tumor immunity to precision medicine: the next step in B7-H3/CD276 research.从肿瘤免疫到精准医学:B7-H3/CD276研究的下一步
Med Rev (2021). 2025 Mar 3;5(3):260-264. doi: 10.1515/mr-2025-0003. eCollection 2025 Jun.
3
Tissue-agnostic biomarkers in solid tumors: current approvals and emerging candidates.实体瘤中的组织非特异性生物标志物:当前获批情况及新兴候选物

本文引用的文献

1
B7-H3 promotes colorectal cancer angiogenesis through activating the NF-κB pathway to induce VEGFA expression.B7-H3 通过激活 NF-κB 通路诱导 VEGFA 表达促进结直肠癌血管生成。
Cell Death Dis. 2020 Jan 23;11(1):55. doi: 10.1038/s41419-020-2252-3.
2
Tim-3 suppresses the killing effect of Vγ9Vδ2 T cells on colon cancer cells by reducing perforin and granzyme B expression.Tim-3 通过降低穿孔素和颗粒酶 B 的表达来抑制 Vγ9Vδ2 T 细胞对结肠癌细胞的杀伤作用。
Exp Cell Res. 2020 Jan 1;386(1):111719. doi: 10.1016/j.yexcr.2019.111719. Epub 2019 Nov 11.
3
A novel spleen-resident immature NK cell subset and its maturation in a T-bet-dependent manner.
Cancer Metastasis Rev. 2025 Jun 27;44(3):58. doi: 10.1007/s10555-025-10274-2.
4
Revealing the mechanisms and therapeutic potential of immune checkpoint proteins across diverse protein families.揭示不同蛋白质家族中免疫检查点蛋白的作用机制和治疗潜力。
Front Immunol. 2025 Apr 28;16:1499663. doi: 10.3389/fimmu.2025.1499663. eCollection 2025.
5
Tumor Immunotherapy Targeting B7-H3: From Mechanisms to Clinical Applications.靶向B7-H3的肿瘤免疫疗法:从作用机制到临床应用
Immunotargets Ther. 2025 Mar 27;14:291-320. doi: 10.2147/ITT.S507522. eCollection 2025.
6
Gamma delta T cells and their immunotherapeutic potential in cancer.γδ T细胞及其在癌症中的免疫治疗潜力。
Biomark Res. 2025 Mar 28;13(1):51. doi: 10.1186/s40364-025-00762-6.
7
Characterisation of Cytotoxicity-Related Receptors on γδ T Cells in Chronic Lymphocytic Leukaemia.慢性淋巴细胞白血病中γδT细胞上细胞毒性相关受体的特征分析
Cells. 2025 Mar 18;14(6):451. doi: 10.3390/cells14060451.
8
CD276 as a critical independent biomarker and immune checkpoint inhibitor target in epithelioid mesothelioma-TCGA study.CD276作为上皮样间皮瘤的关键独立生物标志物和免疫检查点抑制剂靶点——TCGA研究
J Thorac Dis. 2025 Jan 24;17(1):109-120. doi: 10.21037/jtd-24-1598. Epub 2025 Jan 22.
9
A Pan-Cancer Analysis of the Oncogenic Role of CD276 in Human Tumors.CD276在人类肿瘤中致癌作用的泛癌分析
Genes (Basel). 2024 Nov 27;15(12):1527. doi: 10.3390/genes15121527.
10
B7-H3 in glioblastoma and beyond: significance and therapeutic strategies.胶质母细胞瘤及其他疾病中的B7-H3:意义与治疗策略
Front Immunol. 2024 Nov 25;15:1495283. doi: 10.3389/fimmu.2024.1495283. eCollection 2024.
一种新型的脾脏驻留未成熟 NK 细胞亚群及其在 T-bet 依赖性方式下的成熟。
J Autoimmun. 2019 Dec;105:102307. doi: 10.1016/j.jaut.2019.102307. Epub 2019 Jul 24.
4
Development of immune checkpoint therapy for cancer.癌症免疫检查点治疗的发展。
J Exp Med. 2019 Jun 3;216(6):1244-1254. doi: 10.1084/jem.20182395. Epub 2019 May 8.
5
B7-H3 promotes aerobic glycolysis and chemoresistance in colorectal cancer cells by regulating HK2.B7-H3 通过调节 HK2 促进结直肠癌细胞的有氧糖酵解和化疗耐药性。
Cell Death Dis. 2019 Apr 5;10(4):308. doi: 10.1038/s41419-019-1549-6.
6
Boosting γδ T cell-mediated antibody-dependent cellular cytotoxicity by PD-1 blockade in follicular lymphoma.通过阻断程序性死亡受体1增强滤泡性淋巴瘤中γδ T细胞介导的抗体依赖性细胞毒性作用
Oncoimmunology. 2018 Dec 17;8(3):1554175. doi: 10.1080/2162402X.2018.1554175. eCollection 2019.
7
PD-1 signaling modulates interferon-γ production by Gamma Delta (γδ) T-Cells in response to leukemia.程序性死亡受体1(PD-1)信号通路通过γδ T细胞调节干扰素-γ的产生,以应对白血病。
Oncoimmunology. 2018 Dec 14;8(3):1550618. doi: 10.1080/2162402X.2018.1550618. eCollection 2019.
8
IL-21-mediated expansion of Vγ9Vδ2 T cells is limited by the Tim-3 pathway.IL-21 通过 Tim-3 通路限制 Vγ9Vδ2 T 细胞的扩增。
Int Immunopharmacol. 2019 Apr;69:136-142. doi: 10.1016/j.intimp.2019.01.027. Epub 2019 Jan 29.
9
TGF-β enhances the cytotoxic activity of Vδ2 T cells.转化生长因子-β增强Vδ2 T细胞的细胞毒性活性。
Oncoimmunology. 2018 Sep 26;8(1):e1522471. doi: 10.1080/2162402X.2018.1522471. eCollection 2019.
10
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.